Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TICA-MASTICA: Chewed vs Swallowed Ticagrelor in ACS
NCT04567290Phase 4Unknown
- Sponsor
- Centro Hospitalario La Concepción
- Start
- Oct 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in acute coronary syndrome (ACS), sponsored by Centro Hospitalario La Concepción. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04567290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04567290.